These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 979648)

  • 1. Neurotensin and substance-P: effects on plasma insulin and glucagon levels.
    Brown M; Villarreal J; Vale W
    Metabolism; 1976 Nov; 25(11 Suppl 1):1459-61. PubMed ID: 979648
    [No Abstract]   [Full Text] [Related]  

  • 2. Effects of neurotensin and substance P on plasma insulin, glucagon and glucose levels.
    Brown M; Vale W
    Endocrinology; 1976 Mar; 98(3):819-22. PubMed ID: 1261503
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neurotensin hyperglycemia:evidence for histamine mediation and the assessment of a possible physiologic role.
    Nagai K; Frohman LA
    Diabetes; 1978 May; 27(5):577-82. PubMed ID: 648748
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of somatostatin on neurotensin-induced glucagon release and hyperglycemia.
    Ukai M; Inoue I; Itatsu T
    Endocrinology; 1977 May; 100(5):1284-6. PubMed ID: 849724
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of substance P and neurotensin infused intrapancreatically on glucagon and insulin secretion.
    Kaneto A; Kaneko T; Kajinuma H; Kosaka K
    Endocrinology; 1978 Feb; 102(2):393-401. PubMed ID: 743963
    [No Abstract]   [Full Text] [Related]  

  • 6. Effects of substance-P [PROCEEDINGS].
    Sasaki H
    Metabolism; 1976 Nov; 25(11 Suppl 1):1463. PubMed ID: 979649
    [No Abstract]   [Full Text] [Related]  

  • 7. Effects of neurotensin and substance P on insulin and glucagon release by the perfused dog pancreas [proceedings].
    Patton G; Brown M; Dobbs R; Vale W; Unger RH
    Metabolism; 1976 Nov; 25(11 Suppl 1):1465. PubMed ID: 790094
    [No Abstract]   [Full Text] [Related]  

  • 8. Portal vein blood insulin and glucagon are increased in experimental hyperthyroidism.
    Wolf E; Eisenstein AB
    Endocrinology; 1981 Jun; 108(6):2109-13. PubMed ID: 7014195
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of oral glucose and protein load on plasma glucagon and insulin concentrations in small for gestational age infants.
    Salle BL; Ruiton-Ugliengo A
    Pediatr Res; 1977 Feb; 11(2):108-12. PubMed ID: 840499
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glucoregulatory effects of intrahypothalamic injections of bombesin and other peptides.
    Iguchi A; Matsunaga H; Nomura T; Gotoh M; Sakamoto N
    Endocrinology; 1984 Jun; 114(6):2242-6. PubMed ID: 6202499
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insulin and glucagon breakthrough of somatostatin suppression: importance of portal vein hormone measurements.
    Polonsky K; Jaspan J; Pugh W; Dhorajiwala J; Abraham M; Blix P; Moossa AR
    Diabetes; 1981 Aug; 30(8):664-9. PubMed ID: 6114006
    [No Abstract]   [Full Text] [Related]  

  • 12. Dissociation of systemic and central effects of neurotensin on the secretion of growth hormone, prolactin, and thyrotropin.
    Maeda K; Frohman LA
    Endocrinology; 1978 Nov; 103(5):1903-9. PubMed ID: 107023
    [No Abstract]   [Full Text] [Related]  

  • 13. Persistent pancreatic glucagon but not insulin response to arginine in pancreatectomized dogs.
    Mashiter K; Harding PE; Chou M; Mashiter GD; Stout J; Diamond D; Field JB
    Endocrinology; 1975 Mar; 96(3):678-93. PubMed ID: 1116479
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potential endocrine effects of hypothalamic peptide "neurotensin" on pancreas in dogs.
    Kawanishi K; Goto A; Ishida T; Kawamura K; Nishina Y; Machida S; Yamamoto S; Ofuji T
    Acta Med Okayama; 1978 Aug; 32(4):301-8. PubMed ID: 153091
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of peripheral insulin/glucagon levels by rat liver.
    Balks HJ; Jungermann K
    Eur J Biochem; 1984 Jun; 141(3):645-50. PubMed ID: 6378634
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Hyperglycemic action of galanin with reference to insulin and glucagon].
    Yoshimura T; Norii E; Tanaka H; Mabe T; Tobe R
    Nihon Shokakibyo Gakkai Zasshi; 1985 Jul; 82(7):1806. PubMed ID: 2416972
    [No Abstract]   [Full Text] [Related]  

  • 17. Effect of intraventricular injection of neurotensin and other various bioactive peptides on plasma immunoreactive somatostatin levels in rat hypophysial portal blood.
    Abe H; Chihara K; Chiba T; Matsukura S; Fujita T
    Endocrinology; 1981 May; 108(5):1939-43. PubMed ID: 6163624
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of neurotensin (NT)-induced glucagon release by [D-Trp11]-NT1.
    Ukai M; Itatsu T; Shibata A; Rioux F; St-Pierre S
    Experientia; 1982 Oct; 38(10):1222-4. PubMed ID: 6754419
    [No Abstract]   [Full Text] [Related]  

  • 19. Pancreatic innervation is not essential for exercise-induced changes in glucagon and insulin or glucose kinetics.
    Coker RH; Koyama Y; Lacy DB; Williams PE; Rhèaume N; Wasserman DH
    Am J Physiol; 1999 Dec; 277(6):E1122-9. PubMed ID: 10600803
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cholecystokinin octapeptide, caerulein, substance P, neurotensin, and angiotensin II: species-typical effects on the isolated portal vein of guinea pig and rat.
    Zetler G; Overbeck B
    Pharmacology; 1987; 34(1):30-6. PubMed ID: 2437599
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.